Clinical Trial Update: PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating the PPIO-004 efficacy-prediction model using epigenomics sequencing in neoadjuvant immunotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED